Your browser doesn't support javascript.
loading
Neoadjuvant endocrine therapy with or without palbociclib in low-risk patients: a phase III randomized double-blind SAFIA trial.
Alsaleh, K; Al Zahwahry, H; Bounedjar, A; Oukkal, M; Saadeddine, A; Mahfouf, H; Bouzid, K; Bensalem, A; Filali, T; Abdel-Razeq, H; Larbaoui, B; Kandil, A; Abulkhair, O; Al Foheidi, M; Ghosn, M; Rasool, H; Boussen, H; Mezlini, A; Haddaoui, A; Ayari, J; Al Ghamdi, M; Errihani, H; Abdel-Aziz, N; Arafah, M; Dabouz, F; Bahadoor, M; Kullab, S; Nabholtz, J M.
Afiliação
  • Alsaleh K; College of Medicine, King Saud University, King Saud University Medical City (KSUMC), Oncology Center, Riyadh, 12372, Saudi Arabia. khalid_alsaleh@hotmail.com.
  • Al Zahwahry H; National Cancer Institute (NCI), Cairo University, Cairo, Egypt.
  • Bounedjar A; Anti-Cancer Center, Blida, Algeria.
  • Oukkal M; Medical Oncology Department/Beni-Messous University Hospital, Algiers, Algeria.
  • Saadeddine A; Oncology Center, King Abdulaziz Medical City (KAMC), Riyadh, Saudi Arabia.
  • Mahfouf H; Medical Oncology EPH, Rouiba, Algeria.
  • Bouzid K; Oncology Center of Pierre Et Marie Curie, Algiers, Algeria.
  • Bensalem A; Dr. Benbadis University Hospital, Constantine, Algeria.
  • Filali T; Constantine University Hospital, Constantine, Algeria.
  • Abdel-Razeq H; King Hussein Cancer Center (KHCC), Amman, Jordan.
  • Larbaoui B; Oncology Center of Emir Abdelkader, Oran, Algeria.
  • Kandil A; Alexandria University, Alexandria, Egypt.
  • Abulkhair O; Specialized Medical Center (SMC), Riyadh, Saudi Arabia.
  • Al Foheidi M; Oncology Center of Princess Noorah, King Abdulaziz Medical City (KAMC), Jeddah, Saudi Arabia.
  • Ghosn M; Hematology-Oncology Department/Hotel Dieu de France/University Saint Joseph, Beirut, Lebanon.
  • Rasool H; King Faisal Specialist Hospital and Research Center (KFSHRC), Jeddah, Saudi Arabia.
  • Boussen H; Faculty of Medicine, University Tunis El Manar, Abderrahmen Mami Hospital, Tunis, Ariana, Tunisia.
  • Mezlini A; Medical Oncology Department, Tunis, Tunisia.
  • Haddaoui A; Medical Oncology Department, Tunis, Tunisia.
  • Ayari J; Faculty of Medicine Tunis, Oncology Department, University Tunis El Manar, Military Hospital of Tunis, Tunis, Tunisia.
  • Al Ghamdi M; Oncology center, King Saud University Medical City (KSUMC), King Saud University, Riyadh, 12372, Saudi Arabia.
  • Errihani H; Medical Oncology, National Institute of Oncology, University Mohammed V, Rabat, Morocco.
  • Abdel-Aziz N; Oncology Center, King Saud University Medical City (KSUMC), King Saud University, Riyadh, Saudi Arabia.
  • Arafah M; Department of Pathology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Dabouz F; International Cancer Research Group (ICRG), Sharjah, UAE.
  • Bahadoor M; International Cancer Research Group (ICRG), Sharjah, UAE.
  • Kullab S; Oncology center, King Saud University Medical City (KSUMC), King Saud University, Riyadh, 12372, Saudi Arabia.
  • Nabholtz JM; Oncology center, King Saud University Medical City (KSUMC), King Saud University, Riyadh, 12372, Saudi Arabia.
J Cancer Res Clin Oncol ; 149(9): 6171-6179, 2023 Aug.
Article em En | MEDLINE | ID: mdl-36680581

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Estradiol Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: J Cancer Res Clin Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Arábia Saudita

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Estradiol Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: J Cancer Res Clin Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Arábia Saudita
...